Skip to search formSkip to main contentSkip to account menu

PCA 4248

Known as: PCA-4248 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Dihydropyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
PCA-4248 : un antagonista del receptor del PAF con actividad terapéutica potencial en el shock séptico
El factor activador de plaquetas (paf) es un mediador fosfolipidico implicado en muchos procesos fisiologicos y patologicos… 
2002
2002
Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
PURPOSE To test whether platelet-activating factor (PAF) directly causes retinovascular endothelial cell (EC) death. METHODS… 
2002
2002
PAF-Stimulated Protein Tyrosine Phosphorylation in Hippocampus: Involvement of NO Synthase
The effect of platelet-activating factor (PAF) on protein tyrosine phosphorylation was studied in rat hippocampal slices. PAF… 
1995
1995
Studies on the mechanism of PAF-induced vasopermeability in rat lungs.
1995
1995
PCA-4248, a PAF receptor antagonist, inhibits PAF-induced phosphoinositide turnover.
1994
1994
Platelet-activating factor inhibits (Na+,K+) ATPase activity in rat brain
1993
1993
New 4-alkyl-1,4-dihydropyridines: evaluation of photostability and phototoxic potential.
1993
1993
Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)